HCON 182 ENR: Recognizing the need to pursue research U.S. House of Representatives 2007-10-17 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

IV One Hundred Tenth Congress of the United States of America At the First SessionBegun and held at the City of Washington on Thursday, the fourth day of January, two thousand and seven H. CON. RES. 182 October 17, 2007 Agreed to CONCURRENT RESOLUTION Recognizing the need to pursue research into the causes, a treatment, and an eventual cure for idiopathic pulmonary fibrosis, supporting the goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, and for other purposes.

Whereas idiopathic pulmonary fibrosis is a serious lung disorder causing progressive, incurable lung scarring; Whereas idiopathic pulmonary fibrosis is one of about 200 disorders called interstitial lung diseases; Whereas idiopathic pulmonary fibrosis is the most common form of interstitial lung disease; Whereas idiopathic pulmonary fibrosis is a debilitating and generally fatal disease marked by progressive scarring of the lungs, causing an irreversible loss of the lung tissue’s ability to transport oxygen; Whereas idiopathic pulmonary fibrosis progresses quickly, often causing disability or death within a few short years; Whereas there is no proven cause of idiopathic pulmonary fibrosis; Whereas more than 128,000 United States citizens have idiopathic pulmonary fibrosis, and more than 48,000 new cases are diagnosed each year representing a 156-percent increase in mortality since 2001; Whereas idiopathic pulmonary fibrosis is often misdiagnosed or under diagnosed; Whereas the median survival rate for idiopathic pulmonary fibrosis patients is 2 to 3 years; about two-thirds of idiopathic pulmonary fibrosis patients die within 5 years; and approximately 40,000 patients die each year; and Whereas a need has been identified to increase awareness and detection of this misdiagnosed and under diagnosed disorder as well as all incarnations of pulmonary fibrosis: Now, therefore, be it

That the Congress— (1)recognizes the need to pursue research into the causes, a treatment, and an eventual cure for idiopathic pulmonary fibrosis; (2)supports the work of advocates and organizations in educating, supporting, and providing hope for individuals who suffer from idiopathic pulmonary fibrosis, including efforts to organize a National Idiopathic Pulmonary Fibrosis Awareness Week; (3)supports the designation of an appropriate week as National Idiopathic Pulmonary Fibrosis Awareness Week; (4)welcomes the issuance of a proclamation designating a National Idiopathic Pulmonary Fibrosis Awareness Week; (5)congratulates advocates and organizations for their efforts to educate the public about idiopathic pulmonary fibrosis, while funding research to help find a cure for this disorder; and (6)supports the goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week.

Clerk of the House of Representatives. Secretary of the Senate.